junk

FTC challenges ‘junk’ drug patents. Here’s what they are and why they matter

by
FTC challenges 'junk' drug patents. Here's what they are and why they matter

The US Federal Trade Commission (FTC) announced last week that, for the second time, dispute hundreds of rubbish patents listed in the Food and Drug Administrations (FDA) Orange Book, a …

Read more

Sanders praises FTC challenge of ‘junk’ patents for drugs, including Ozempic | common dreams

by
Sanders praises FTC challenge of 'junk' patents for drugs, including Ozempic | common dreams

US Sen. Bernie Sanders on Tuesday praised the Biden administration for expanding its “campaign against pharmaceutical manufacturers’ incorrect or inaccurate patent listing” for a wide range of drugs, including Novo …

Read more